ACCELERATING DRUG DISCOVERY THROUGH DISEASE-RELEVANT
CELL MODELS

Advance scientific discoveries with our comprehensive suite of preclinical services, including iPSC solutions, Genome Editing, In Vitro Assays, and more. Explore our extensive range of human and animal primary cells, iPSCs, and customizable models for disease research.

Advancing Drug Discovery
with iPSC Solutions and Primary Cell Models

Offering iPSCs, primary cells, genome editing, and advanced characterization, we deliver trusted solutions that drive discovery in drug development and disease modeling.

LATEST NEWS IN ALS DRUG DISCOVERY

Advancing Precision Medicine for ALS

XCells Biotechnologies has been selected to lead the first pilot for Project Mosaic, a groundbreaking effort to fix the 99% failure rate in ALS drug development. By creating patient-specific disease models, this collaboration aims to open the door to precision therapies for the majority of ALS patients. Read the article here.

Let us help accelerate your next breakthrough.

Backed by proven scientific leadership and next-generation platforms, we’re ready to support your journey from discovery to precision medicine. Reach out and let’s begin.

LATEST NEWS

iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine Effort

Advancing Precision Medicine for ALS

XCells Biotechnologies has been selected to lead the first pilot for Project Mosaic, a groundbreaking effort to fix the 99% failure rate in ALS drug development. By creating patient-specific disease models, this collaboration aims to open the door to precision therapies for the majority of ALS patients.

Read the article.

Let us help accelerate your next breakthrough.

Backed by proven scientific leadership and next-generation platforms, we’re ready to support your journey from discovery to precision medicine. Reach out and let’s begin.

Advancing Drug Discovery
with iPSC Solutions and Primary Cell Models

Test Latest News

Cell Portfolio

An extensive catalog of human and animal primary cells from healthy and diseased tissues to complement our collection of iPSCs and their derivatives.

PRECLINICAL CRO SERVICES

We offer iPSC reprogramming, Cas9 genome editing, directed differentiation, custom cell isolation, in vitro assays, and ASO screening services. Our team of PhD scientists provides disease-relevant, patent-derived models that accelerate drug discovery and disease understanding.

APPLICATIONS

We specialize in complex assay development and execution for research support. Our expertise includes multi-cellular model building, 3D liver model signaling studies, and compound screening for iPSC-derived neurons and human immune cells.

DISCOVER
OUR CRO SERVICES

What Your Peers say about us

Unlock a world of benefits!

Subscribe now and be among the first to enjoy exclusive product offers, indulge in premium content, and be the first to witness exciting new product launches.

    Advancing Precision Medicine for ALS

    XCells Biotechnologies has been selected to lead the first pilot for Project Mosaic, a groundbreaking effort to fix the 99% failure rate in ALS drug development. By creating patient-specific disease models, this collaboration aims to open the door to precision therapies for the majority of ALS patients.

    Read the article.

    Let us help accelerate your next breakthrough.

    Backed by proven scientific leadership and next-generation platforms, we’re ready to support your journey from discovery to precision medicine. Reach out and let’s begin.